# Caffeinol Hypothermia Protocol

> **NCT00299416** · PHASE1,PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 30 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Caffeinol
- **PROCEDURE:** hypothermia

## Key facts

- **NCT ID:** NCT00299416
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2009-01
- **Final completion:** 2009-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2011-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00299416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00299416, "Caffeinol Hypothermia Protocol". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00299416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*